{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:18:32Z","timestamp":1764937112593,"version":"3.37.3"},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  BACKGROUND:  Non-alcoholic fatty liver disease has been progressively diagnosed in the general population as a consequence of the increased prevalence of obesity and type 2 diabetes mellitus, its main risk factors. It is characterized by accumulation of fat in the hepatocytes associated with lobular inflammation and balonization, which can lead to cirrhosis and hepatocarcinoma. Thus, a characterization and follow-up of a progression of the fibrosis level of these patients becomes important, being that the transient hepatic elastography is a reliable method for this evaluation with a measure of the kapa index.  OBJECTIVE:  To evaluate the progression of hepatic fibrosis through elastography in patients with non-alcoholic fatty liver disease.  METHODS:  Patients who had previously performed hepatic biopsy and noninvasive scores for non-alcoholic steatohepatitis (NASH) and fibrosis were included in the study. These same subjects were then submitted to current clinical evaluation, laboratory and liver elastography tests, defining the level of liver fibrosis, about 10 years after the first evaluation.  RESULTS:  Data were analyzed for 66 patients previously submitted to liver biopsy. Of these, 16 were not found, four could not participate because they were debilitated due to hepatic cirrhosis, two had died from an automobile accident and five from complications of cirrhosis of the liver. Therefore, of the 50 patients with a known history, 9 (18%) had died of cirrhosis or were unable to attend the examination because of their liver disease. The remaining population was predominantly female (61.5%), mean age of 63 years, being overweight, dyslipidemia (76.9%), disorders of the glycemic profile (76.9%), and metabolic syndrome (82.1%). Of the 39 cases evaluated, 35% had the same degree of fibrosis at the initial evaluation (biopsy) and at the current evaluation (elastography), 33% had an increase in the degree of fibrosis and another 30% had a decrease in the degree of fibrosis. Twenty-eight patients had NASH at baseline. Regarding these patients, it was observed in the current evaluation, that 25% remained stable in the degree of fibrosis, 39% progressed, and 35% regressed.  CONCLUSION:  Despite some limitations of our study, such as the small number of patients, and the use of two different methods of evaluation (biopsy and elastography), the data obtained allow us to conclude that of the 39 evaluated cases, 33% (13) presented progression of fibrosis and the total group of 50 patients, 42% had cirrhosis or died due to liver disease. The presence of NASH on hepatic biopsy did not prove to be, in our study, a predictive of the evolution of hepatic fibrosis in the patients.<\/jats:p>","DOI":"10.1590\/s0004-2803.201900000-48","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T23:12:10Z","timestamp":1569712330000},"page":"256-260","source":"Crossref","is-referenced-by-count":8,"title":["EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS"],"prefix":"10.1590","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8609-0486","authenticated-orcid":false,"given":"Paula Cenira Senger de","family":"CASTRO","sequence":"first","affiliation":[{"name":"Hospital Nossa Senhora das Gra\u00e7as,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2088-3432","authenticated-orcid":false,"given":"Helen Caroline Perussolo","family":"ALBERTON","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora das Gra\u00e7as,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-3402","authenticated-orcid":false,"given":"Maria Lucia Alves","family":"PEDROSO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1060-7431","authenticated-orcid":false,"given":"Daphne Benatti Gon\u00e7alves","family":"MORSOLETTO","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora das Gra\u00e7as,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9573-9438","authenticated-orcid":false,"given":"Alcindo","family":"PISSAIA JUNIOR","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora das Gra\u00e7as,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-557X","authenticated-orcid":false,"given":"Cl\u00e1udia Alexandra Pontes","family":"IVANTES","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora das Gra\u00e7as,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000318741","article-title":"Obesity affects the liver - the link between adipocytes and hepatocytes","volume":"83","author":"Wree A","year":"2011","journal-title":"Digestion"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams LA","year":"2005","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan\u00ae) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?","volume":"22","author":"Mikoselavic I","year":"2016","journal-title":"World Journal of Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease. Nature Reviews","volume":"7","author":"Brunt EM","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner DE","year":"2005","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey DC","year":"2009","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MOG.0b013e328343e9a3","article-title":"Noninvasive tools to assess liver disease","volume":"27","author":"Clark PJ","year":"2011","journal-title":"Current Opinion in Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VW","year":"2010","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/2359-3997000000233","article-title":"Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?","volume":"61","author":"Nones RB","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2893.2011.01534.x","article-title":"Novel controlled atenuation parameter for noninvasive assessment of steatosis using Fibroscan: validation in chronic hepatitis C","volume":"19","author":"Sasso M","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography","volume":"32","author":"de L\u00e9dinghen V","year":"2012","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"31421","DOI":"10.1038\/srep31421","article-title":"Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease","volume":"6","author":"Gallego-dur\u00e1n R","year":"2016","journal-title":"Scientific Reports"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis","volume":"377","author":"Dhiel AM","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.20323","article-title":"Portal Fibrosis and Hepatic Steatosis in Morbidly Obese Subjects: A Spectrum of Nonalcoholic Fatty Liver Disease","volume":"40","author":"Abrams GA","year":"2004","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4254\/wjh.v3.i8.219","article-title":"Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"3","author":"Uslusoy HS","year":"2011","journal-title":"World J Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/hepr.12039","article-title":"Transient elastography for monitoring the fibrosis of non-alcoholic fatty liver disease for 4 years","volume":"43","author":"Suzuki K","year":"2013","journal-title":"Hepatol Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo CK","year":"2009","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VW","year":"2010","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh S","year":"2015","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v56n3\/1678-4219-ag-56-03-256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T14:58:18Z","timestamp":1581433098000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032019000300256&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["S0004-28032019000300256"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.201900000-48","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"type":"electronic","value":"1678-4219"},{"type":"print","value":"0004-2803"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}